Literature DB >> 10894862

The treatment of advanced gastric cancer: in search of the right combination.

M H Kulke.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10894862     DOI： 10.1200/JCO.2000.18.14.2645

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  The efficacy of docetaxel and cisplatin combination chemotherapy for the treatment of advanced gastric cancer after failing to 5-fluorouracil based chemotherapy.

Authors:  Sang-Joon Shin; Min-Kyoung Kim; Kyung-Hee Lee; Myung-Soo Hyun; Sang Woon Kim; Sun Kyo Song; Sung-Hwa Bae; Hun-Mo Ryoo
Journal:  Cancer Res Treat       Date:  2004-12-31       Impact factor: 4.679

Review 2.  Status of treatment for advanced gastric carcinoma.

Authors:  James Y Tsai; Howard Safran
Journal:  Curr Oncol Rep       Date:  2003-05       Impact factor: 5.075

3.  Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer.

Authors:  P C Enzinger; D P Ryan; J W Clark; A Muzikansky; C C Earle; M H Kulke; J A Meyerhardt; L S Blaszkowsky; A X Zhu; P Fidias; M M Vincitore; R J Mayer; C S Fuchs
Journal:  Ann Oncol       Date:  2009-01-12       Impact factor: 32.976

4.  Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer.

Authors:  W Koizumi; S Tanabe; K Saigenji; A Ohtsu; N Boku; F Nagashima; K Shirao; Y Matsumura; M Gotoh
Journal:  Br J Cancer       Date:  2003-12-15       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.